Navigation Links
UK company to demonstrate their commercially effective graphene production process
Date:4/6/2012

Haydale, a wholly owned subsidiary of British company Innovative Carbon Limited today announces that they will be exhibiting at Graphene 2012 from 10th April to 13th.

Graphene, a sheet of carbon just one atom thick, has been described as the new wonder material. First isolated at Manchester University in 2004, for which the team was awarded a Nobel Prize, the race has been on to produce it commercially. To support this work the UK Government recently announced a 50m investment into developing a research and technology hub to explore the commercialisation of Graphene. Similarly the EU has pledged 100m annually for the next 10 years looking at the exploitation of Graphene in Information and Communication Technology (ICT) and consumer applications.

The major players in this industry will be coming together at an international conference in Brussels next week. Haydale, based in South Wales and with close ties to leading UK Universities will be part of the British contingent. Their unique patented plasma based technology, which is winning plaudits around the world, enables the scaleable production of Graphene Nano Platelets (GNPs) from powdered graphite. The process can now produce commercial quantities of a consistently high quality in an economic and environmentally friendly way.

There are a vast array of applications for Graphene, but in Brussels Haydale will be displaying a range of current offerings produced via their novel patented process, including a transparent conductive membrane that could be a competitor of Indium Tin Oxide (one of the key components in photovoltaic cells and touch screen devices); graphene loaded polymer pellets; samples of GNPs and a conductive ink, capable of replacing some silver based products. The ink has many applications and could positively impact on the radio frequency identification and security industry. Haydale will have their scientists and engineers at the show to discuss these and other potenti
'/>"/>

Contact: Trevor Phillips
trevor.phillips@hermesfinancialpr.co.uk
44-788-915-3628
Hermes Financial Public Relations
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Regado Biosciences, Inc. to Present at Needham & Companys 11th Annual Healthcare Conference in New York, NY
2. Nycomed, a Takeda Company, Launches OmnarisĀ® Nasal Spray in the UAE for the Treatment of Allergic Rhinitis
3. Receptos to Present at the Cowen and Company 32nd Annual Health Care Conference
4. Incline Therapeutics to Present at the Cowen and Company 32nd Annual Health Care Conference
5. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
6. Aneesh Chopra to Serve as Senior Advisor to The Advisory Board Company
7. Meaningful Use Stage Two: The Advisory Board Company Helps Hospitals Set Strategy
8. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
9. Oxford Finance Provides $15 Million Senior Secured Credit Facility to Private Equity Backed Healthcare Services Company
10. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
11. Monsanto Declared Worst Company of 2011 by NaturalSociety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... April 30, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... announced that it has commenced an underwritten public offering ... grant the underwriters a 30-day option to purchase up ... common stock offered in the public offering. The offering ... no assurance as to whether or when the offering ...
(Date:4/30/2015)... , April 30, 2015 The following is ... of Directors of China Cord Blood Corp (NYSE: CO ... special committee of the independent directors of China Cord Blood ... privatization offer of $6.40 per share from Golden Meditech Holdings ... $6.40 per share would greatly benefit Golden Med and Mr. ...
(Date:4/30/2015)... , April 30, 2015  Pfenex Inc. ... in the development of biosimilar therapeutics including high ... the closing of its previously announced underwritten public ... at a public offering price of $15.50 per ... the underwriters of their option to purchase up ...
(Date:4/30/2015)... WuXi PharmaTech (Cayman) Inc. ("WuXi" or the "Company") (NYSE: ... provider, today announced that its board of directors has ... 2015, from a consortium (the "Consortium") led by Dr. ... chief executive officer of the Company, and Ally Bridge ... "Transaction") involving the acquisition of all outstanding shares of ...
Breaking Biology Technology:BioAmber Inc. Announces Public Offering Of Common Stock 2BioAmber Inc. Announces Public Offering Of Common Stock 3April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 2April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 3April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 4April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 5Pfenex Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 2WuXi PharmaTech Announces Receipt of Proposal 2WuXi PharmaTech Announces Receipt of Proposal 3WuXi PharmaTech Announces Receipt of Proposal 4WuXi PharmaTech Announces Receipt of Proposal 5WuXi PharmaTech Announces Receipt of Proposal 6
... Genetics, the parent company of Myeloma Health, a privately ... announced the formation of their Scientific Advisory Board. They ... Director, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer ... Medical School Dr. Anderson of Dana-Farber Cancer ...
... AutoGenomics, a leader in providing automated, molecular testing solutions ... the U.S. Food and Drug Administration to market its ... *2, *3, *17, of the CYP450 2C19 gene and ... testing platform, the INFINITI® Analyzer.   "We ...
... ("China-Biotics", the "Company") (Nasdaq: CHBT ), the ... China, today announced it will host a conference call ... Beijing Time on Tuesday, November 9, 2010, to discuss ... financial results for the period ended September 30, 2010. ...
Cached Biology Technology:Signal Genetics Announces Establishment of Scientific Advisory Board 2Signal Genetics Announces Establishment of Scientific Advisory Board 3AutoGenomics Receives FDA Clearance for its INFINITIĀ® CYP2C19 Assay 2China-Biotics to Report Fiscal Year 2011 Second Quarter Financial Results on November 9 2
(Date:4/17/2015)... , April 17, 2015 ... security concerns, and technological advancement to drive biometric ... until 2020   According to ... Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems market ... projected to register growth at CAGR of over ...
(Date:4/13/2015)... April 13, 2015 According ... "Global Biometrics Market Forecast & Opportunities, 2020", the global ... of around 14% till 2020. The biometrics market ... scale implementation and review of biometric management systems. ... new products with greater efficiency, are resulting in ...
(Date:4/9/2015)... Synaptics Inc. (NASDAQ: SYNA ), a leading ... will report financial results for the third quarter of ... close of market. The company will host a corresponding ... PT (5:00 p.m. ET), during which management may discuss ... live call, analysts and investors should dial 888-438-5524 (conference ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2Synaptics to Report Third Quarter Results on April 23 2
... Science Research Conference on focuses on recent advances in ... transcriptional regulators, currently numbering 17, and will also include ... Held twice previously, this FASEB Conference is the ... The major themes of the conference will be the ...
... medicine? The media are invited to register now for ... Clinical Genetics Meeting, March 25-29, 2014 at the Nashville ... Sequencing to Cancer Genetics, the focus of the ACMG ... genomics in healthcare, showcasing the latest breakthroughs in genetics ...
... European consortium of epilepsy researchers has reported the discovery ... Using a novel combination of technologies, including trio exome ... tiny larvae of zebrafish, the EuroEPINOMICS RES consortium found ... a subset of epilepsy patients with symptoms similar to ...
Cached Biology News:Complimentary press registration now open for ACMG 2014 Annual Clinical Genetics Meeting 2European epilepsy consortium identifies new gene for severe childhood epilepsy 2European epilepsy consortium identifies new gene for severe childhood epilepsy 3European epilepsy consortium identifies new gene for severe childhood epilepsy 4
Polyclonal Antibody to PRG3...
Goat polyclonal to MLH3 ( Abpromise for all tested applications). entrezGeneID: 27030 SwissProtID: Q9UHC1...
Mouse monoclonal [2991] to C3a / C3a des Arg ( Abpromise for all tested applications). SwissProtID: P01024...
Polyclonal Antibody to SHPRH...
Biology Products: